Poorer ART outcomes with increasing age at a large public sector HIV clinic in Johannesburg, South Africa

Journal of the International Association of Physicians in AIDS Care

Volumn 11, Issue 1, 2012, Pages 57-65

  Maskew, Mhairi ^a   Brennan, Alana T ^a,b   MacPhail, A Patrick ^a,c   Sanne, Ian M ^a,c   Fox, Matthew P ^a,b,d  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^c RIGHT TO CARE   (South Africa)

^d BOSTON UNIVERSITY   (United States)

Author keywords

age; antiretroviral; HIV; loss to follow up; mortality; treatment response

Indexed keywords

ADULT; AGE; ANTIVIRAL THERAPY; ARTICLE; CD4 LYMPHOCYTE COUNT; CONFIDENCE INTERVAL; FEMALE; FOLLOW UP; HAZARD RATIO; HIGH RISK PATIENT; HOSPITAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; MORTALITY; ORGANIZATION AND MANAGEMENT; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SOUTH AFRICA; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGE FACTORS; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; FEMALE; HIV INFECTIONS; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; SOUTH AFRICA; TREATMENT OUTCOME; VIRAL LOAD; YOUNG ADULT;

EID: 84856857488     PISSN: 15451097     EISSN: 15570886     Source Type: Journal    
DOI: 10.1177/1545109711421641     Document Type: Article

References (43)

1. Rosen S, Fox M, Gill CG. Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Med. 2007 ; 4 (10). e298
2. Fox M, Rosen S. Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007-2009: systematic review. Trop Med Int Health. 2010 ; 15 (suppl 1). 1-15
3. Schneider MF, Gange SJ, Williams CM, et al. Patterns of the hazard of death after AIDS through the evolution of antiretroviral therapy: 1984-2004. AIDS 2005. 19 (17). 2009-2018
4. Kaufmann GR, Furrer H, Ledergerber B, et al. Characteristics, determinants, and clinical relevance of CD4 T cell recovery to 1500 cells/mL in HIV type 1-infected individuals receiving potent antiretroviral therapy. Clin Infect Dis. 2005 ; 41 (3). 361-372 (Pubitemid 41022115)
5. Hunt PW, Deeks SG, Rodriguez B, et al. Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapy. AIDS. 2003 ; 17 (13). 1907-1915 (Pubitemid 37070276)
6. Cohen CJ, Hunt S, Sension M, et al. A randomized trial assessing the impact of phenotypic resistance testing on antiretroviral therapy. AIDS. 2002 ; 16 (4). 579-588 (Pubitemid 34218853)
7. Gandhi RT, Spritzler J, Chan E, et al. Effect of baseline- and treatment-related factors on immunologic recovery after initiation of antiretroviral therapy in HIV-1-positive subjects: results from ACTG 384. J Acquir Immune Defic Syndr. 2006 ; 42 (4). 426-434 (Pubitemid 44050889)
8. Greenbaum AH, Wilson LE, Keruly JC, Moore RD, Gebo KA. Effect of Age and HAART regimen on clinical response in an urban cohort of HIV-infected Individuals. AIDS. 2008 ; 22 (17). 2331-2339
9. Viard JP, Mocroft A, Chiesi A, et al. Influence of age on CD4 cell recovery in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy: evidence from the EuroSIDA study. J Infect Dis. 2001 ; 183 (8). 1290-1294 (Pubitemid 32281572)
10. Yamashita TE, Phair JP, Munoz A, et al. Immunologic and virologic response to highly active antiretroviral therapy in the Multicenter AIDS Cohort Study. AIDS. 2001 ; 15 (6). 735-746 (Pubitemid 32423221)
11. Grabar S, Kousignian I, Sobel A, et al. Immunologic and clinical responses to highly active antiretroviral therapy over 50 years of age: results from the French hospital database on HIV. AIDS. 2004 ; 18 (15). 2029-2038 (Pubitemid 39463356)
12. Knobel H, Guelar A, Valldecillo G, et al. Response to highly active antiretroviral therapy in HIV-infected patients aged 60 years or older after 24 months follow-up. AIDS. 2001 ; 15 (12). 1591-1593 (Pubitemid 32744614)
13. Kalayjian RC, Landay A, Pollard RB, et al. Age-related immune dysfunction in health and in human immunodeficiency virus (HIV) disease: association of age and HIV infection with naive CD8+ cell depletion, reduced expression of CD28 on CD8+ cells, and reduced thymic volumes. J Infect Dis. 2003 ; 187 (12). 1924-1933 (Pubitemid 36724491)
14. Tumbarello M, Rabagliati R, de Gaetano DK, et al. Older HIV-positive patients in the era of highly active antiretroviral therapy: changing of a scenario. AIDS. 2003 ; 17 (1). 128-131 (Pubitemid 36106310)
15. Tumbarello M, Rabagliati R, de Gaetano DK, et al. Older age does not influence CD4 cell recovery in HIV-1 infected patients receiving highly active antiretroviral therapy. BMC Infect Dis. 2004 ; 4: 46
16. Grimes RM, Otiniano ME, Rodriguez-Barradas MC, Lai D. Clinical experience with human immunodeficiency virus-infected older patients in the era of effective antiretroviral therapy. Clin Infect Dis. 2002 ; 34 (11). 1530-1533 (Pubitemid 34553714)
17. FleishmanAGeboKAMooreRD. Disparities in virologic suppression among patients with HIV infection. In: Program and abstracts of the 22nd Annual Academy Health Annual Research Meeting, San Diego, CA; 2004. http://www.academyhealth.org/files/2004/abstracts/generalposters.pdf. Accessed September 5, 2011.
18. Goodkin K, Shapshak P, Asthana D, et al. Older age and plasma viral load in HIV-1 infection.. AIDS. 2004 ; 18 (suppl 1). S87 - S98
19. Manfredi R, Calza L, Cocchi D, Chiodo F. Antiretroviral treatment and advanced age: epidemiologic, laboratory, and clinical features in the elderly. J Acquir Immune Defic Syndr. 2003 ; 33 (1). 112-114 (Pubitemid 36547249)
20. Perez JL, Moore RD. Greater effect of highly active antiretroviral therapy on survival in people aged >50 years compared with younger people in an urban observational cohort. Clin Infect Dis. 2003 ; 36 (2). 212-218 (Pubitemid 36143421)
21. National Antiretroviral Treatment Guidelines. 2004 ;:
22. Fairall LR, Bachmann MO, Louwagie GM, et al. Effectiveness of antiretroviral treatment in a South African program: a cohort study. Arch Intern Med. 2008 ; 168 (1). 86-93
23. Fox MP, Brennan AB, Maskew M, MacPhail P, Sanne I. Using vital registration data to update mortality among patients lost to follow-up from ART programmes: evidence from the Themba Lethu Clinic, South Africa. Trop Med Int Health. 2010 ; 15 (4). 405-413
24. Boulle A, Van Cutsem G, Hilderbrand K, et al. Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa. AIDS. 2010 ; 24 (4). 563-572
25. Interim WHO Clinical Staging of HIV/AIDS and HIV/AIDS Case Definitions for Surveillance. 2005 ;:
26. Onen NF, Overton ET, Seyfried W, et al. Aging and HIV infection: a comparison between older HIV-infected persons and the general population. HIV Clin Trials. 2010 ; 11 (2). 100-109
27. Justice AC, Dombrowski E, Conigliaro J, et al. Veterans aging cohort study (VACS): overview and description. Med Care. 2006 ; 44 (8 suppl 2). S13 - S24
28. Silverberg MJ, Leyden W, Horberg MA, DeLorenze GN, Klein D, Quesenberry CP. Older age and the response to and tolerability of antiretroviral therapy. Arch Intern Med. 2007 ; 167 (7). 684-691 (Pubitemid 46598461)
29. Response to combination antiretroviral therapy: variation by age. AIDS 2008. 22 (12). 1463-1473
30. Shisana O, Rehle T, Simbayi LC, et al. South African National HIV Prevalence, Incidence, Behaviour and Communication Survey 2008: a Turning Tide Among Teenagers?. 2009 ;:
31. Pettifor AE, Maesham DM, Rees HV, Padian NS. Sexual power and HIV risk, South Africa. Emerging Infectious Diseases. 2004 ; 10 (11). 1996-2004 (Pubitemid 39458571)
32. Shisana O, Rehle T, Simbayi LC, et al. South African National HIV Prevalence, HIV Incidence, Behaviour and Communication Survey. 2005 ;:
33. Leclerc-Madlala S. Age-disparate and intergenerational sex in Southern Africa: the dynamics of hypervulnerability. AIDS. 2008 ; 22 (suppl 4). S17 - S25
34. Giordano TP, Gifford AL, White AC, et al. Retention in care: a challenge to survival with HIV infection. Clin Infect Dis. 2007 ; 44 (11). 1493-1499 (Pubitemid 46801595)
35. Park WB, Choe PG, Kim SH, et al. One-year adherence to clinic visits after highly active antiretroviral therapy: a predictor of clinical progress in HIV patients. J Intern Med. 2007 ; 261 (3). 268-275
36. Watts DH. Teratogenicity risk of antiretroviral therapy in pregnancy. Curr HIV/AIDS Rep. 2007 ; 4 (3). 135-140 (Pubitemid 47493054)
37. Nachega JB, Hislop M, Dowdy DW, et al. Efavirenz versus nevirapine-based initial treatment of HIV infection: clinical and virological outcomes in Southern African adults. AIDS. 2008 ; 22 (16). 2117-2125
38. Rates of disease progression according to initial highly active antiretroviral therapy regimen: a collaborative analysis of 12 prospective cohort studies. J Infect Dis. 2006 ; 194 (5). 612-622
39. Braithwaite RS, Kozal MJ, Chang CCH, et al. Adherence, virological and immunological outcomes for HIV-infected veterans starting combination antiretroviral therapies. AIDS. 2007 ; 21 (12). 1579-1589 (Pubitemid 47075479)
40. Mbuagbaw LCE, Irlam JH, Spaulding A, Rutherford GW, Siegfried N. Efavirenz or nevirapine in three-drug combination therapy with two nucleoside-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals. Cochrane Database Syst Rev. 2010 ;: 12
41. Hinkin CH, Hardy DJ, Mason KI, et al. Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse. AIDS. 2004 ; 18 (suppl 1). S19 - S25
42. Schatz E, Ogunmefun C. Caring and contributing: the role of older women in rural South African ulti-generational households in the HIV/AIDS Era. World Development. 2007 ; 35: 1390-1403 (Pubitemid 47099456)
43. Hosegood V, Preston-Whyte E, Busza J, Moitse S, Timaeus IM. Revealing the full extent of households' experiences of HIV and AIDS in rural South Africa. Soc Sci Med. 2007 ; 65 (6). 1249-1259 (Pubitemid 47260644)